Solid Biosciences (SLDB) Retained Earnings (2017 - 2024)
Historic Retained Earnings for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to -$740.9 million.
- Solid Biosciences' Retained Earnings fell 1605.27% to -$740.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$740.9 million, marking a year-over-year decrease of 1605.27%. This contributed to the annual value of -$658.8 million for FY2023, which is 1706.21% down from last year.
- Solid Biosciences' Retained Earnings amounted to -$740.9 million in Q3 2024, which was down 1605.27% from -$708.1 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Retained Earnings registered a high of -$343.0 million during Q1 2020, and its lowest value of -$740.9 million during Q3 2024.
- For the 5-year period, Solid Biosciences' Retained Earnings averaged around -$529.9 million, with its median value being -$527.2 million (2022).
- In the last 5 years, Solid Biosciences' Retained Earnings plummeted by 5000.7% in 2020 and then crashed by 1468.83% in 2024.
- Solid Biosciences' Retained Earnings (Quarter) stood at -$404.6 million in 2020, then fell by 17.84% to -$476.8 million in 2021, then fell by 18.03% to -$562.7 million in 2022, then dropped by 17.06% to -$658.8 million in 2023, then decreased by 12.47% to -$740.9 million in 2024.
- Its Retained Earnings stands at -$740.9 million for Q3 2024, versus -$708.1 million for Q2 2024 and -$683.1 million for Q1 2024.